| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $192.1M | +16.1% | +9.3% |
| Cost of Revenue | $19.0M | +12.7% | +7.9% |
| R&D Expense | $29.4M | +32.8% | +1.1% |
| SG&A Expense | $179.7M | +92.1% | +157.6% |
| Operating Income | -$60.2M | -596.1% | -247.5% |
| Pre-tax Income | -$58.0M | -447.7% | -229.0% |
| Income Tax | -$12.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $151.4M | +4.6% | +377.9% |
| Accounts Receivable | $171.3M | +21.6% | +17.8% |
| Inventory | $107.1M | +143.3% | +67.4% |
| Current Assets | $593.9M | -19.6% | -7.2% |
| Total Assets | $1.42B | +2.7% | +5.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $27.5M | — | — |
| Capital Expenditures | $911K | — | — |
| Investing Cash Flow | $55.4M | — | — |
| Financing Cash Flow | $604K | — | — |
| Free Cash Flow | $26.6M | — | — |
| -120.2% |
| -299.1% |
| Net Income | -$45.1M | -300.5% | -217.2% |
| EPS (Basic) | -$0.80 | -300.0% | -214.3% |
| EPS (Diluted) | -$0.80 | -300.0% | -215.9% |
| $330.6M |
| +15.5% |
| +13.4% |
| Total Liabilities | $370.1M | +16.2% | +10.3% |
| Stockholders' Equity | $1.05B | -1.3% | +4.2% |